Latest Phenethylamines Stories

Canadian scientists also confirm previous research showing possible link between cannabis dependence and schizophrenia TORONTO, Nov. 8, 2011 /PRNewswire/ - In the first worldwide study of its kind, scientists from Toronto's Centre for Addiction and Mental Health (CAMH) found evidence that heavy methamphetamine users might have a higher risk of developing schizophrenia. This finding was based on a large study comparing the risk among methamphetamine users not only to a group that...

Amphetamine use in adolescence can cause neurobiological imbalances and increase risk-taking behaviour, and these effects can persist into adulthood, even when subjects are drug free. These are the conclusions of a new study using animal models conducted by McGill University Health Centre (MUHC) researcher Dr. Gabriella Gobbi and her colleagues. The study, published today in The International Journal of Neuropsychopharmacology, is one of the first to shed light on how long-term amphetamine...

A research team led by investigators at the Virginia Tech Carilion Research Institute has demonstrated the first rapid measurements of dopamine release in a human brain and provided preliminary evidence that the neurotransmitter can be tracked in its movement between brain cells while a subject expresses decision-making behavior. "In an experiment where we measured dopamine release while a subject made investment decisions in a stock market trading game, we showed that dopamine tracks...

REDWOOD CITY, Calif., Oct. 28, 2011 /PRNewswire/ -- Pearl Therapeutics Inc. presented data elucidating the robust aerosol performance and physicochemical foundations of the Company's cosuspension technology which uses spray-dried, low-density porous particles to deliver drug microcrystals via pressurized metered dose inhalers (MDIs). Two posters were presented this week at the 25th American Association of Pharmaceutical Scientists annual meeting in Washington DC. "These results demonstrate...

DEA has exercised its emergency scheduling authority to control and regulate chemicals commonly abused. Often marketed as "bath salts" or "plant food", these chemicals are dangerous and potentially deadly and represent an imminent threat to public health and safety, prompting DEA action. These chemicals mainly come from overseas and are commonly repackaged and distributed at the retail level. Washington, DC (PRWEB) October 21, 2011 The United States Drug Enforcement...

Children with certain dopamine system gene variants have an improved response to methylphenidate - the most commonly prescribed medication for Attention Deficit Hyperactivity Disorder - in a finding that could help eliminate the guesswork from prescribing effective medications for children with ADHD. Researchers reporting their results in the Oct. 21 Journal of the American Academy of Child and Adolescent Psychiatry tested 89 children with ADHD between ages 7 and 11. They found that...

SAN DIEGO, Oct. 20, 2011 /PRNewswire/ -- HGH.com announces its plan to give away a 1 year supply of any of its HGH, Body Building, or Muscle Gaining supplements. Customers can choose which product they want a 1 year supply of. All they have to do is send in a video testimonial of their favorite product, or how HGH.com helped them achieve a successful weight gain, muscle gain, or weight loss campaign using their proprietary vitamin pills. HGH.com is known for its leading edge products in the...

Scientists have developed a way to evaluate new treatments for some forms of attention deficit disorder. Working in mice, researchers at Washington University School of Medicine in St. Louis showed that they can use brain scans to quickly test whether drugs increase levels of a brain chemical known as dopamine. In a study published last year, the same group found that raising dopamine levels in mice alleviates attention deficits caused by neurofibromatosis type 1 (NF1), a condition that...

Urgently needed tests which could help identify the manufacturers of designer 'legal high' drugs are being developed in research led at the University of Strathclyde in Glasgow. The drugs, known by names such as 'ivory wave' and NRG-1" and sold labelled as bath salts, plant food and incense, mimic the effects of illegal drugs such as amphetamine, cocaine and ecstasy. Although these so-called 'designer drugs' can be dangerous, many have not yet been made illegal and are difficult to detect...

AUSTIN, Texas, Oct. 11, 2011 /PRNewswire/ -- Edgemont Pharmaceuticals, LLC, a neuroscience focused company, today announced that the U.S. Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for Fluoxetine Tablets 60 mg. Fluoxetine, originally marked in the U.S. under the brand name Prozac®, has become a widely-known and used treatment for Major Depressive Disorder, Obsessive Compulsive Disorder in adults and pediatrics, and Bulimia Nervosa and Panic Disorder...